Unknown

Dataset Information

0

Germline mutations of inhibins in early-onset ovarian epithelial tumors.

ABSTRACT: To identify novel genetic bases of early-onset epithelial ovarian tumors, we used the trio exome sequencing strategy in a patient without familial history of cancer who presented metastatic serous ovarian adenocarcinomas at 21 years of age. We identified a single de novo mutation (c.1157A>G/p.Asn386Ser) within the INHBA gene encoding the ?A-subunit of inhibins/activins, which play a key role in ovarian development. In vitro, this mutation alters the ratio of secreted activins and inhibins. In a second patient with early-onset serous borderline papillary cystadenoma, we identified an unreported germline mutation (c.179G>T/p.Arg60Leu) of the INHA gene encoding the ?-subunit, the partner of the ?A-subunit. This mutation also alters the secreted activin/inhibin ratio, by disrupting both inhibin A and inhibin B biosynthesis. In a cohort of 62 cases, we detected an additional unreported germline mutation of the INHBA gene (c.839G>A/p.Gly280Glu). Our results strongly suggest that inhibin mutations contribute to the genetic determinism of epithelial ovarian tumors.

SUBMITTER: Tournier I 

PROVIDER: S-EPMC4284000 | biostudies-literature | 2014 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

To identify novel genetic bases of early-onset epithelial ovarian tumors, we used the trio exome sequencing strategy in a patient without familial history of cancer who presented metastatic serous ovarian adenocarcinomas at 21 years of age. We identified a single de novo mutation (c.1157A>G/p.Asn386Ser) within the INHBA gene encoding the βA-subunit of inhibins/activins, which play a key role in ovarian development. In vitro, this mutation alters the ratio of secreted activins and inhibins. In a  ...[more]

Similar Datasets

Unknown Prevalence of PALB2 Germline Mutations in Early-onset and Familial Breast/Ovarian Cancer Patients from Pakistan.
| S-EPMC6639217 | biostudies-literature
Unknown CDH1/E-cadherin germline mutations in early-onset gastric cancer.
| S-EPMC2563190 | biostudies-literature
Unknown Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease.
| S-EPMC4129488 | biostudies-literature
Unknown Early onset HER2-positive breast cancer is associated with germline TP53 mutations.
| S-EPMC3527897 | biostudies-literature
Unknown Deleterious Germline BLM Mutations and the Risk for Early-onset Colorectal Cancer.
| S-EPMC4566092 | biostudies-literature
Unknown Rare germline mutations in African American men diagnosed with early-onset prostate cancer.
| S-EPMC6912854 | biostudies-literature
Unknown Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations.
| S-EPMC4304103 | biostudies-literature
Unknown Identification of Germline Mutations in Melanoma Patients with Early Onset, Double Primary Tumors, or Family Cancer History by NGS Analysis of 217 Genes.
| S-EPMC7601281 | biostudies-literature
Unknown Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancer.
| S-EPMC3625496 | biostudies-literature
Unknown The genetic epidemiology of early-onset epithelial ovarian cancer: a population-based study.
| S-EPMC1288384 | biostudies-literature